abstract |
An object of the present invention is to provide a therapeutic agent for type 2 diabetes having a sufficient insulin sensitivity-enhancing action and a low possibility of causing side effects such as lactic acidosis. SOLUTION: The following general formula (1): Embedded image (In the formula, R 1 , R 2 , and R 3 each represent any one selected from the group consisting of a hydrogen atom, an optionally substituted lower alkyl group, and an optionally substituted lower alkylthio group.) A therapeutic agent for type 2 diabetes, comprising a biguanide derivative represented by the following formula or a salt thereof as an active ingredient. [Selection diagram] None |